Portfolio
Portfolio

Cytheris

Developing a human recombinant IL-7 for the treatment of diseases that are caused by lymphopenia.

Cytheris is a biopharmaceutical company developing a human recombinant Interleukin 7 (IL-7) for the treatment of diseases that are caused by lymphopenia (low lymphocytes).

Discontinued operations in 2013.

  • Industry Biotech
  • History Other